The report highlighted several other takeaways from the market’s activity over the past quarter:
- The strongest performers were National Research and Medidata, posting gains of 112 percent and 34 percent, respectively.
- Two of the weakest performers were Greenway and Vocera, posting declines of 22 percent and 36 percent, respectively.
- The initial public offering market saw 15 new technology filings, the most since the third quarter of 2011.
- Venture capital funds raised $2.9 billion this quarter, down 33 percent from last quarter, and down 54 percent compared with the second quarter of 2012.
- The number of venture capital firms held steady at 44, and these firms invested $7 billion in more than 800 deals this quarter, down 14 percent over the same quarter last year.
- The number of deals raising more than $5 million increased 66 percent over the prior quarter and 40 percent over the same period last year, to 36.
- Global merger and acquisition activity in this market has reached its lowest level since 2009, with deal volume falling 8 percent since last quarter and 28 percent compared with the second quarter last year, to $470 billion.
- While M&A activity in the U.S. is down 16 percent in the second quarter with 20 deals announced, it is up 34 percent for the year.
More Articles on Health IT Markets:
10 Trends That Will Shape mHealth Through 2017
Healthcare Cloud Computing Market to Grow to $5.4B, Thanks to PPACA
E-Prescribing Market to Hit $794M by 2017
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
